The question on everybody's mind this week was when will the declines end? Was that the so much talked about capitulation? Have the stock markets bottomed?
Well, I can't answer that, and suffice it to say that many market analysts, fundamental and technical, are still quite gloomy. Pretty much all we can do in this time is hope for flat performance from a few select stocks, which perhaps would yield good returns once the economy starts rebounding and the bear market has completed its course.
Here are some picks and pans from the past week from BloggingStocks contributors:
Research in Motion (NASDAQ: RIMM) -- Steven Halpern brought a recommendation from one of The Forbes Wireless Stock Watch advisors, Nikhil Hutheesing. In Hutheesing's words: "In the long run, smart investments today will lead to profits down the road. One of those companies, that I now think looks attractive, is the Canadian maker of the BlackBerry." Not only is RIMM's corporate business strong, it is also working on getting its phones to consumers. In addition, it has lots of cash and little to no long-term debt and great prospects, what the advisor is looking for in addition to value and fundamentals in this environment.
Lear Corp. (NYSE: LEA) is an auto parts supplier. Jamie Dlugosch bets on a bailout for the auto industry here. Today, Lear has a $110 million market capitalization, down from its peak within the last 52 weeks of $2.6 billion. If the bailout finally happens, owners of LEA could benefit greatly.
Yesterday, in response to Chasing Value: ISRG is falling and I'm buying I received the following comment from Beltway Greg, "You're a brave dude. Why? I've watched this stock for awhile and I worry about possible entry by other folks into the market."
Brave perhaps, even foolish on occasion, but I still think this is the time to be selectively buying equities.
To those that might be concerned about competition for Intuitive Surgical Inc (NASDAQ: ISRG) you will be interested in the following:
NOTICE TEXT: Department of the Army U.S. Army Medical Command MEDCOM, North Atlantic Regional Contracting Office Subject: Contract prosthetic feet and leg coverings This is a notice of the Governments intent to solicit, negotiate and award a sole source contract (Note 22) contract to Intuitive surgical for Implants based on urgency. This is not a set-aside for small business. This notice is an urgent requirement for Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Washington, DC 20307, contract number W91YTZ-09-P-0147. Parties interested in future announcements shall provide detailed information of their capabilities and certifications to clearly meet the requirements stated above.
It is possible that someday ISRG will have some competition, but there does not seem to be anything on the horizon for now. Furthermore, as the user base expands the barrier to entry increases and the cost of changing systems becomes more challenging.
The most likely scenario for competition would be if another manufacturer were to create a similar system for procedures not yet addressed by ISRG's Di Vinci robotic surgical units. Some of the potential competitors, like Johnson and Johnson (NYSE: JNJ) or Medronic (NYSE: MDT), are actually corporate partners helping to distribute the units world wide. What is most likely from my point of view is that other manufacturers will find a way to partner with ISRG to develop complimentary hardware to expand the capability of the system for more procedures to get to market faster.
Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture & planning firm. He writes the columns Chasing Value and Serious Money.
One of my top holdings, Intuitive Surgical Inc (NASDAQ: ISRG) and favorite stocks is taking a beating this morning and has been along with almost everything else. One of our readers who has been following this story line sent me an email asking what my current thoughts on the subject are. Andrew:
"I'm just curious if you hung on to your ISRG or if you bailed on it... I've been following it since this article, and man, its really heading down to the boiler room... Doctors seeem to be making cuts all over the place, and it looks like ISRG is being taken for a ride... I'm looking at getting in, but maybe if it hits 112 to even as low as sub 100... But I'm curious how you've taken to it?"
As the old saying goes in regards to the stock market, beware trying to catch a falling knife. Regardless, I have been a buyer of late. But first questions first. We did sell 20% of our position for a large gain just under $200 per share, having originally bought in at $7.70. We did not bail out but we did take our original money off the table, and then some.
It was only two weeks ago I posted about one of the stocks I own and follow closely Chasing Value: Intuitive Surgical Earnings -- what now?, a company that I consider an "Obama pick". My frequent readers know that the company is one of my older investments and one that has paid off handsomely. Although Intuitive Surgical Inc. (NASDAQ: ISRG) may still be a profitable investment at it's current level, at this point, it is well covered.
Searching for something less known, and certainly more controversial, I have the ideal Obama stock pick to add to your watchlist, StemCell Inc. (NASDA: STEM) which closed yesterday at $1.90. per share. It is not profitable, spends heavily on Research and Development and is highly speculative. So was ISRG when I got in very early.
The company profile states that STEM "discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and Alzheimer's disease, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant."
The first time I bought Intuitive Surgical Inc (NASDAQ: ISRG) I paid around $7 per share and that is about the lowest point since it went public. Those shares have been sitting in our portfolio as our largest position and our best investment for quite some time.
ISRG makes computer assisted robotic surgical equipment to assist doctors in a growing range of less invasive procedures.
Until today I hesitated to buy more because the stock was jumping so fast that I always thought it was slightly ahead of the value. Each time it just went up more.
After the market closed yesterday ISRG reported an increase in revenue and earnings.
Revenues for the quarter grew 50% over the same period last year. The company's third quarter 2008 net income was $57.6 million, up 41% from $40.9 million reported for the third quarter of 2007. Earnings per share increased to $1.44 from $1.04 in the prior-year comparable quarter. Eleven analysts polled by First Call/Thomson Financial expected the company to earn $1.27 per share for the quarter.
Even though the company beat earnings expectations by $0.17 (13.38%) a share the stock dropped almost 16% a share, since yesterday. Until today I watched the stock go from $7.00, to as high as $359.59, its all-time high and stayed on the sidelines except to buy a little for my kids shortly after our company got in.
Today, with the share price 50% off its high; with investors afraid of their own shadows; with world financial markets in turmoil; I bought more at $180 per share. That is 10 times what my kids shares cost and almost 26 times what I first paid.
This one is a keeper and one of the few stocks besides Berkshire Hathaway (NYSE: BRK.A) that I have ever recommended that does not pay a dividend. Even Warren Buffett has been buying and recently posted a bullish story in the NY Times. The following is the five-year chart for ISRG.
This charming pic-toon of moderation comes from one of my talented long time friends, Ron Overmyer, who has allowed me to share it with our readers. He does a weekly email blast and this is one of his tamer commentaries, one that might give us pause to consider what it means to be objective.
I thought I would take a moment to shout out to any moderates in the audience and say that I too have worried that some of my colleagues may have sacrificed their reputations for objectivity by writing some posts that could be viewed as borderline paid political announcements. Some readers have quipped that this should be included in the disclosure. However, on the occasion that this is true, it is usually so blatant that I would characterize such disclosure as redundant.
Several of my posts contain political commentary but I think our posts should be about investing, not swaying voter opinion. I especially avoid one-sided rationalizations that appear to have a specific agenda -- although I readily admit that on occasion the dividing line may be very fine indeed.
I still have not made up my mind about the upcoming election because I find some merit in the positions of each candidate. But to me the real question on our site remains: where do you put your money in the case of either candidate's success?
During my various commutes over the past week I have been hearing a new radio commercial about Intuitive Surgical Inc. (NASDAQ: ISRG). The City of Hope Hospital in Los Angeles is advertising their Di Vinci robotic surgical procedures to attract patients.
They use the catch phrase "The science of saving lives" while promoting less invasive surgical procedures, shorter hospital stays, and faster recovery. These are well-known themes among the medical profession and investors but it is the first time I have heard the story promoted for a competitive advantage among hospitals. I am sure it won't be the last.
Certainly this will raise the bar among other hospitals competing for similar business and simply to keep their Di Vinci operating rooms productive, cost effective, and profitable. It also means that any hospital without the equipment will soon be deemed second rate, if they are not already.
Perhaps we will soon be hearing competing hospitals bragging about having multiple Di Vinci's or more trained doctors or the highest number of procedures or new procedures. Where will it end? When it is common place and every hospital is using the system.
Have you heard any radio advertising from hospitals in your city? Fans of Elvis Costello can check out Radio, Radio" at Last fm. here.
ISRG closed last Friday at $299.17 and is trading down slightly this morning. It has been hovering around $300 for the past two weeks.
Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture & planning firm. He writes the columns Chasing Value and Serious Money. DISCLOSURE: I currently own shares of ISRG and BRK.B.
This week's Barron's (subscription required) finally had Intuitive Surgical (NASDAQ: ISRG) on its cover, and cover it it did, but with a wet blanket.
The stock is down in early trading today, but that is probably warranted given the runup last week when it jumped $52 in one day after it reported one more mind boggling quarter. I only exaggerate slightly as the company beat estimates by 10 cents a share and increased margins in all areas, when I reported then, Chasing Value: Intuitive Surgical beat the street AGAIN!
The Barron's story, Surgical Robot Cuts Both Ways by Andrew Barry questions the stock's valuation and the company's projections of expanding sales and service figures.
Mr. Barry points out that the stock is trading at sky high valuations and that any disappointment could result in a 25% drop in the stock price. I would remind ISRG fans and stock watchers that this has happened on many occasions without any bad news. It had reached a high around $360 per share and then traded down until it took a dive into the $240s when Wall Street decided that the slowing economy and tighter fiscal restraint on the part of hospital administrators would dampen ISRG's prospects in the second half of 2008.
My favorite company, Intuitive Surgical Inc. (NASDAQ: ISRG), the maker of the da Vinci Surgical System reported earnings Tuesday afternoon that creamed Street guesstimates by 10 cents per share. Intuitive posted earnings per share of $1.28 versus analyst consensus of $1.18.
For the 23rd quarter in a row, just like clockwork and without missing a beat, Intuitive's top and bottom line growth simply ignored the global economy, blazing its own trail. I wonder how ISRG would have done if the economy was not in the dumps?
Overall, second quarter revenue shot up 56% from $142.2 million to $219.2 million. Instruments and accessories revenue increased 61% to $73.6 million from $45.8 million. Training revenue increased 44% to $29.4 million from $20.3 million during the second quarter of 2007.
Lonnie Smith, Chairman and CEO of Intuitive Surgical, said, "We are pleased with our second quarter revenue and earnings growth. These results reflect the continued adoption of the da Vinci Surgical System platform across a broadening group of surgical procedures."
Six months of 2008 are now behind us and the stock market has not been a friendly place to most investors. Stability that was once found in household names that were industry giants is gone, and they have now been brought to their knees.
Many of them were the stocks we might have looked to in the past for stability, so you can be sure I put forward my five candidates with a little trepidation, but forward I go anyway. First a little review is in order.
Citigroup Inc. (NYSE: C) dropped from around $53 per share last year to around $30 in January and we can buy it today for around $17. Even at that price Goldman Sachs (NYSE: GS) has downgraded it to a sell and thinks there is more bad news to come. Citigroup was the largest bank in the world. Not any more.
General Motors (NYSE: GM) was the largest car maker in the world. That was before the stock tumbled from $43 to its current $11 range. A crushing blow to long time investors hoping that someone in the company could stop the ship from sinking.
MOST NOTEWORTHY: Lehman Brothers, Nokia and Intuitive Surgical were today's noteworthy initiations:
Morgan Stanley initiated Lehman Brothers (NYSE:LEH) with an Overweight rating and $31 target. The firm believes Lehman's discount to book value prices in significant write-downs.
Bernstein believes Nokia (NYSE:NOK) will see a slowdown in demand for devices and could loss market share. Shares were initiated with an Underperform rating.
Merriman assumed Intuitive Surgical (NASDAQ:ISRG) with a Neutral rating and believes the tightened credit markets could impact capital equipment spending for small and mid-sized hospitals. They find shares appropriately valued at current levels.
After a tough day yesterday Chasing Value: Intuitive Surgical confounds Wall Street and closed down to a recent low of $274.75. It opened up today on the news and is currently trading up about 4% to $285 per share, in a market that is trading down across the board.
The following five-year chart illustrates the rapid rise of this highly specialized company that produces a robotic surgical device called the "da Vinci System". They own all the patents for the hardware, software, replacement parts, and service contracts too. That is one big moat around this company.
If you were following my post last year you might have read Serious Money: You asked about Intuitive Surgical? when ISRG was trading in the low $120's. Since that time it has reached $359.59 -- not a bad return. I have been following ISRG since the beginning and own shares at $7.70 the lowest entry point possible post IPO.
The irony of this story is that I also recommended Bear Stearns last year so my best stock pick ever is replacing one of my worst. Intuitive Surgical belongs on your watch list, and if it dips again during the sumer doldrums perhaps there might be another buying opportunity.
UPDATE: ISRG finished the day at $284.77 up $10.02 (+3.65%)
Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture & planning firm. He writes the columns Chasing Value and Serious Money. Disclosure: I own shares of ISRG.